Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Quercetin may help with PCOS symptoms, but more research is needed.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

COVID-19 may harm male fertility and damage the reproductive system.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Iraqi women with PCOS often have higher testosterone levels and obesity.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Lower ghrelin levels and certain gene variations may increase acne risk.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Eating nuts, chocolate candy, and red tea might worsen acne, while eating more fresh vegetables could reduce it.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.